☆ 4.7 Article

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats

Raphaelle Corremans et al.

Summary: This study evaluated the therapeutic efficacy of metformin and canagliflozin in slowing the progression of non-diabetic CKD. Metformin showed protective effects against kidney impairment, while canagliflozin did not. Proteomic analysis revealed that metformin's kidney-protective effect was associated with the activation of the Hippo signaling pathway.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Effects of Quercetin Supplementation on Blood Pressure- Meta-Analysis

Joanna Popiolek-Kalisz et al.

Summary: This meta-analysis summarizes the effects of quercetin supplementation on blood pressure, showing that it significantly decreases systolic and diastolic blood pressure in normotensive and (pre)hypertensive patients.

CURRENT PROBLEMS IN CARDIOLOGY (2022)

Add to Collection

Article Plant Sciences

The extract of Polygala fallax Hemsl. slows the progression of diabetic nephropathy by targeting TLR4 anti-inflammation and MMP-2/9-mediated anti-fibrosis in vitro

Minhui Wang et al.

Summary: This study aimed to investigate the effects and mechanisms of Polygala fallax extract (EPF) on high glucose-induced human glomerular mesangial cell (HMC) injury, inflammation, fibrosis, and apoptosis. The results showed that EPF could reverse the hyperproliferation and apoptosis of HMCs induced by high glucose, inhibit the increase in inflammatory factors, and downregulate the expression of TLR4/NF-xB pathway and its downstream factors.

PHYTOMEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy

Xuan Qian et al.

Summary: Under diabetic conditions, the Hippo pathway is inhibited, leading to YAP activation and promoting mesangial cell proliferation. The PI3K/Akt pathway is activated through the regulatory effect of YAP on its repressor, PTEN. Activation of the PI3K/Akt pathway inhibits the Hippo pathway, resulting in nuclear YAP accumulation and accelerating mesangial cell proliferation and DN formation.

ACTA DIABETOLOGICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model

Raphaelle Corremans et al.

Summary: The study successfully developed a rat model of DKD by combining STZ/NAD and oral L-NAME, inducing diabetes, hypertension, and characteristic features of DKD, providing a new animal model for DKD research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Endocrinology & Metabolism

Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop

Yang Zhou et al.

Summary: Type 2 diabetes mellitus (T2DM) is increasing globally, with its complications, particularly diabetic kidney disease (DKD), also on the rise. Increased levels of tenascin-C (TNC) are associated with UACR and hypertension in T2DM patients. In both a rat model of DKD and rat mesangial cells cultured under high glucose conditions, TNC expression levels were elevated. TNC was found to regulate miR-155-5p expression through the TLR4/NF-kappa B p65 pathway, affecting inflammation and fibrosis processes in DKD.

WORLD JOURNAL OF DIABETES (2021)

Add to Collection

Article Medicine, Research & Experimental

Metformin attenuates diabetic renal injury via the AMPK-autophagy axis

Tingli Sun et al.

Summary: This study found that metformin could reduce kidney damage caused by diabetic nephropathy (DN) by activating the AMPK-mTOR-autophagy axis, resulting in decreased oxidative damage, fibrosis, and inflammatory response. This suggests that metformin may be considered as a potential target in the treatment of DN.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement? Comment

Tazeen H. Jafar

LANCET (2021)

Add to Collection

Review Integrative & Complementary Medicine

Flavonoids on diabetic nephropathy: advances and therapeutic opportunities

Qichao Hu et al.

Summary: Flavonoids, a class of active natural products with a wide range of pharmacological effects, have been found to alleviate diabetic nephropathy by regulating oxidative stress and inflammation. The review systematically summarizes the use of common flavonoids for the treatment of diabetic nephropathy, showing promising potential as drugs for this condition.

CHINESE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease

Mohammed Al Za'abi et al.

Summary: The study showed that metformin can effectively alleviate renal damage induced by adenine and STZ, especially when given together. This indicates that metformin may have an inhibitory effect on the progression of CKD in both diabetic and non-diabetic rats.

BIOMOLECULES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A novel polysaccharide obtained from Siraitia grosvenorii alleviates inflammatory responses in a diabetic nephropathy mouse model via the TLR4-NF-κB pathway

Pin Gong et al.

Summary: SGP-1-1 exhibited good inflammation-modulating activity in DN mouse models, alleviating cellular inflammation and tissue damage. Metabolomics analysis revealed potential biomarkers related to DN, and SGP-1-1 inhibited inflammation by regulating the TLR4-NF-kappa B pathway while promoting antioxidant activity.

FOOD & FUNCTION (2021)

Add to Collection

Article Endocrinology & Metabolism

The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease

Soie Kwon et al.

DIABETES CARE (2020)

Add to Collection

Review Endocrinology & Metabolism

Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review

Davida Kruger et al.

DIABETES THERAPY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Significance of Metformin Use in Diabetic Kidney Disease

Daiji Kawanami et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Urology & Nephrology

Renal structure in type 2 diabetes: facts and misconceptions

Angelo Di Vincenzo et al.

JOURNAL OF NEPHROLOGY (2020)

Add to Collection

Review Cell Biology

Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine

Dengyu Yang et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

Add to Collection

Article Medicine, General & Internal

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

V. Perkovic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Editorial Material Urology & Nephrology

Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?

Eiichiro Kanda et al.

KIDNEY INTERNATIONAL (2019)

Add to Collection

Article Pharmacology & Pharmacy

Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway

Lei Du et al.

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection

Review Medicine, General & Internal

Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults

Eiya Bibiana Omozee et al.

JOURNAL OF LABORATORY PHYSICIANS (2019)

Add to Collection

Article Urology & Nephrology

Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder

Ellen Neven et al.

KIDNEY INTERNATIONAL (2018)

Add to Collection

Article Multidisciplinary Sciences

CcI2 deficiency protects against chronic renal injury in murine renovascular hypertension

Sonu Kashyap et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Medicine, Research & Experimental

Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease

Hu Yang et al.

MEDICAL SCIENCE MONITOR (2018)

Add to Collection

Review Urology & Nephrology

Diagnosis of diabetic kidney disease: state of the art and future perspective

Frederik Persson et al.

KIDNEY INTERNATIONAL SUPPLEMENTS (2018)

Add to Collection

Review Cell Biology

Nephroprotective Effects of Metformin in Diabetic Nephropathy

Sreenithya Ravindran et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes

Siwei Zhang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Add to Collection

Review Pharmacology & Pharmacy

NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes

Sachin V. Suryavanshi et al.

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

NF-kappa B signaling in inflammation

Ting Liu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)

Add to Collection

Article Urology & Nephrology

Diabetic Kidney Disease Challenges, Progress, and Possibilities

Radica Z. Alicic et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Add to Collection

Review Endocrinology & Metabolism

Effects of glycaemic management on diabetic kidney disease

Richard J. MacIsaac et al.

WORLD JOURNAL OF DIABETES (2017)

Add to Collection

Review Endocrinology & Metabolism

Role of Acid-Base Homeostasis in Diabetic Kidney Disease

Pascale Khairallah et al.

CURRENT DIABETES REPORTS (2017)

Add to Collection

Article Urology & Nephrology

Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney

Jianchun Chen et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Add to Collection

Article Endocrinology & Metabolism

Urinary biomarker N-acetyl-beta-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy

Gehan Sheira et al.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2015)

Add to Collection

Article Urology & Nephrology

Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes

Venkata. S. Sabbisetti et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Add to Collection

Article Physiology

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

Volker Vallon et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)

Add to Collection

Article Endocrinology & Metabolism

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

F. J. Lavalle-Gonzalez et al.

DIABETOLOGIA (2013)

Add to Collection

Article Urology & Nephrology

Quercetin Ameliorates Diabetic Nephropathy by Reducing the Expressions of Transforming Growth Factor-beta 1 and Connective Tissue Growth Factor in Streptozotocin-Induced Diabetic Rats

Peng-Bin Lai et al.

RENAL FAILURE (2012)

Add to Collection

Review Chemistry, Medicinal

Quercetin: A Treatment for Hypertension?-A Review of Efficacy and Mechanisms

Abigail J. Larson et al.

PHARMACEUTICALS (2010)

Add to Collection

Editorial Material Transplantation

Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more

Joseph V. Bonventre

NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)

Add to Collection

Review Endocrinology & Metabolism

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007

P. Fioretto et al.

DIABETOLOGIA (2008)

Add to Collection

Article Peripheral Vascular Disease

Metformin inhibits cytokine-induced nuclear factor kappa B activation via AMP-activated protein kinase activation in vascular endothelial cells

Yoshiyuki Hattori et al.

HYPERTENSION (2006)

Add to Collection

Article Urology & Nephrology

Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury

WK Han et al.

KIDNEY INTERNATIONAL (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.